Cytek Biosciences (CTKB)
(Real Time Quote from BATS)
$5.91 USD
+0.22 (3.78%)
Updated Apr 23, 2024 12:30 PM ET
1-Strong Buy of 5 1
D Value C Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | -0.01 |
EPS Last Quarter | 0.07 |
Last EPS Surprise | 133.33% |
ABR | 1.67 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.08 |
Next Year | 0.21 |
EPS (TTM) | 0.09 |
P/E (F1) | 69.60 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 44.85M | 48.88M | 223.35M | 265.50M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 46.18M | 50.70M | 255.69M | 308.68M |
Low Estimate | 43.10M | 47.35M | 205.20M | 238.90M |
Year ago Sales | 37.09M | 49.69M | 193.01M | 223.35M |
Year over Year Growth Est. | 20.93% | -1.64% | 15.71% | 18.87% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.01 | -0.01 | 0.08 | 0.21 |
# of Estimates | 2 | 2 | 3 | 3 |
Most Recent Consensus | 0.00 | NA | NA | NA |
High Estimate | 0.00 | 0.00 | 0.21 | 0.35 |
Low Estimate | -0.02 | -0.02 | 0.00 | 0.12 |
Year ago EPS | 0.00 | 0.01 | 0.10 | 0.08 |
Year over Year Growth Est. | NA | -200.00% | -20.00% | 158.33% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 2 | 1 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.01 | -0.01 | 0.08 | 0.21 |
7 Days Ago | -0.01 | -0.01 | 0.08 | 0.21 |
30 Days Ago | -0.01 | -0.01 | 0.03 | 0.14 |
60 Days Ago | -0.03 | -0.02 | 0.02 | 0.13 |
90 Days Ago | -0.02 | -0.01 | 0.08 | 0.13 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.01 | -0.01 | 0.21 | 0.35 |
Zacks Consensus Estimate | -0.01 | -0.01 | 0.08 | 0.21 |
Earnings ESP | 0.00% | 0.00% | 152.00% | 66.67% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.07 | 0.01 | 0.01 | 0.00 | NA |
Estimate | 0.03 | 0.02 | 0.03 | 0.03 | NA |
Difference | 0.04 | -0.01 | -0.02 | -0.03 | -0.01 |
Surprise | 133.33% | -50.00% | -66.67% | -100.00% | -20.84% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more